Investigation of the Safety of an HIV-1 Vaccine Given Intra-muscularly and Intra-nasally to Healthy Female Subjects
Phase 1
Completed
- Conditions
- HIV-1
- Interventions
- Biological: MYM-V101
- First Posted Date
- 2010-03-10
- Last Posted Date
- 2012-07-13
- Lead Sponsor
- Mymetics Corporation
- Target Recruit Count
- 24
- Registration Number
- NCT01084343
- Locations
- 🇧🇪
CEVAC, Ghent, Belgium
© Copyright 2025. All Rights Reserved by MedPath